Conférence: Greg Appelbaum (dpt of Psychiatry, UCSD)
Conférence: Greg Applebaum (dpt of Psychiatry, UCSD)
Les intimes 2024: lecture et concert en hommage à Aloïse Corbaz
CONFERENCE - Fentanyl: Remettre en question le paradigme des soins
Soutenance de thèse - Sciences infirmières - M Frank Spichiger
Journée de la recherche DM-DMLP
Journée de la recherche DM-DMLP: découvrez le programme!
Regulating Medical Artificial Intelligence
Leçon inaugurale de la Pre Patrizia D'Amelio
Conférence du mardi du SUPEA
Conférence du mardi du SUPEA
La santé vue par les juristes
Leçon inaugurale de la Pre Claudia Gamondi
Farewell symposium in honor of Prof. Karin Diserens - SAVE THE DATE !
SCTO Symposium 2024
SCTO Symposium 2024 Vers une recherche efficace fondée sur les données
14.06.2024 - Trouble de la personnalité ou traumatisme complexe ?
Swiss Addiction Training Day
Grand colloque: Randomized clinical trials in surgical research
Actualités et controverses en gastro-entérologie
EPA PsyEpi 2024 - du 11 au 14 Septembre - Dorigny
TRAITEMENT PHARMACOLOGIQUE DANS LE TSA - Enfants & adolescents TSA
Sensibilisation et connaissances actualisées - TSA
Formation continue pour les logopédistes
ADOLESCENCE ET PSYCHOPATHOLOGIE
Conférence du mardi du SUPEA
Lieu: Auditoire Auguste Tissot | BH08 | CHUV
Date et heure: 16.05.2024 à 17h00
Auteur: Greg Applebaum est professeur au Département de Psychiatrie de l'UCSD (University of California, San Diego), il y dirige le Interventional Psychiatry Research Program ainsi que le Human Performance Optimization Lab
Advancements in cognitive neuroscience have provided profound insights into the workings of the human brain and the methods used offer opportunities to enhance performance, cognition, and mental health. Drawing upon interdisciplinary collaborations in the University of California San Diego, Human Performance Optimization Lab, this talk explores the application of cognitive neuroscience principles in three domains to improve human performance and alleviate mental health challenges.
The first section will discuss studies addressing the role of vision and oculomotor function in athletic performance and the potential to train these foundational abilities to improve performance and sports outcomes. The second domain considers the use of electrophysiological measurements of the brain and heart to detect, and possibly predict, errors in manual performance, as shown in a series of studies with surgeons as they perform robot-assisted surgery.
Lastly, findings from clinical trials testing personalized interventional treatments for mood disorders will be discussed in which the temporal and spatial parameters of transcranial magnetic stimulation (TMS) are individualized to test if personalization improves treatment response and can be used as predictive biomarkers to guide treatment selection. Together, these translational studies use the measurement tools and constructs of cognitive neuroscience to improve human performance and well-being.
Disponible en vidéoconférence.
Webex link: https://chuv.webex.com/chuv-en/j.php?MTID=m6bb94f748bc479d6d0a04df6e764d2f2